Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle

S Miyake1, W R Sellers, M Safran

  • 1Department of Adult Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

EID-1 protein inhibits cell differentiation by blocking p300/CBP histone acetylation. Its degradation is linked to cell cycle exit, revealing a novel mechanism coupling differentiation to cell cycle control.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The retinoblastoma tumor suppressor protein (pRB) controls cell proliferation and differentiation through substrate interactions.
  • Identifying cellular targets of pRB is crucial for understanding these processes.

Purpose of the Study:

  • To identify novel cellular substrates involved in pRB-mediated cell cycle control.
  • To investigate the role of EID-1 (E1A-like inhibitor of differentiation 1) in cell differentiation and its relationship with pRB and p300/CBP.

Main Methods:

  • Protein isolation and identification (EID-1).
  • Assays to measure EID-1's effect on p300/CBP histone acetylation activity.
  • Studies on EID-1 degradation via the proteasome.
  • Analysis of EID-1 ubiquitination and its interaction with p300, pRB, and MDM2.

Main Results:

  • EID-1 was identified as a novel protein and a potent inhibitor of cell differentiation.
  • EID-1 inhibits the histone acetylation activity of p300 and CREB-binding protein (CBP).
  • EID-1 undergoes rapid proteasomal degradation upon cell cycle exit, requiring its C-terminal region for binding to p300/pRB and ubiquitination by MDM2.

Conclusions:

  • EID-1 acts as a key regulator linking cell cycle exit to the transcriptional activation of differentiation genes.
  • The interaction and degradation of EID-1 involving pRB, p300/CBP, and MDM2 represent a novel regulatory pathway in cell differentiation.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...